Change from pre-dose baseline in Alanine aminotransferase (ALT) result;Change from pre-dose baseline in Creatine kinase result;Change from pre-dose baseline in Hemoglobin result;Change from pre-dose baseline in Platelets count;Change from pre-dose baseline in RBC count;Change from pre-dose baseline in WBC count;Incidence of adverse events (AEs);Incidence of serious adverse events (SAEs);Time-weighted average changes in SARSCoV-2 RNA levels in nasopharyngeal swabs from baseline to Day 8

Change from pre-dose baseline in Alanine aminotransferase (ALT) result;Change from pre-dose baseline in Creatine kinase result;Change from pre-dose baseline in Hemoglobin result;Change from pre-dose baseline in Platelets count;Change from pre-dose baseline in RBC count;Change from pre-dose baseline in WBC count;Incidence of adverse events (AEs);Incidence of serious adverse events (SAEs);Time-weighted average changes in SARSCoV-2 RNA levels in nasopharyngeal swabs from baseline to Day 8